Debra P. Merrill

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

Yung-Kang Chow, Martin S. Hirsch, Debra P. Merrill et al. · Nature · 1993 · 155 citations

Medicine, Human Retrovirus, Evolutionary Limitations +10

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities

Stefano Rusconi, Mona Moonis, Debra P. Merrill et al. · Antimicrobial Agents and Chemotherapy · 1996 · 147 citations · Full text

Engineering, Smart Polymer, Immunology +19

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon-  A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro

Victoria A. Johnson, Debra P. Merrill, Joseph A. Videler et al. · The Journal of Infectious Diseases · 1991 · 129 citations

Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro

Debra P. Merrill, Mona Moonis, Ting‐Chao Chou et al. · The Journal of Infectious Diseases · 1996 · 100 citations

Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha A

Victoria A. Johnson, Matthew A Barlow, Debra P. Merrill et al. · The Journal of Infectious Diseases · 1990 · 72 citations